We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
AUM
$1.14B
AUM Growth
+$176M
Cap. Flow
+$140M
Cap. Flow %
12.29%
Top 10 Hldgs %
49.55%
Holding
57
New
10
Increased
31
Reduced
9
Closed
4

Sector Composition

1 Financials 27.26%
2 Healthcare 17.23%
3 Consumer Staples 15.85%
4 Consumer Discretionary 11.5%
5 Energy 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPB icon
1
Spectrum Brands
SPB
$2.04B
$90.1M 7.89%
1,714,955
+360,898
+27% +$20M
WWW icon
2
Wolverine World Wide
WWW
$1.51B
$74.1M 6.49%
2,701,360
-1,596,226
-37% -$42M
VTRS icon
3
Viatris
VTRS
$20.1B
$68.7M 6.02%
6,941,000
+946,000
+16% +$9.21M
OWL icon
4
Blue Owl Capital
OWL
$6.43B
$66.1M 5.79%
3,902,531
+1,385,000
+55% +$26.3M
EQH icon
5
Equitable Holdings
EQH
$13.4B
$52.9M 4.64%
1,042,693
+302,850
+41% +$16M
MTCH icon
6
Match Group
MTCH
$9.13B
$49.4M 4.33%
1,399,833
+44,833
+3% +$1.6M
COF icon
7
Capital One
COF
$128B
$47.2M 4.14%
222,079
-43,629
-16% -$9.55M
APO icon
8
Apollo Global Management
APO
$69.4B
$43.5M 3.81%
326,380
+56,380
+21% +$7.98M
BAX icon
9
Baxter International
BAX
$11.7B
$40M 3.5%
1,756,000
+293,500
+20% +$7.44M
JACK icon
10
Jack in the Box
JACK
$286M
$33.5M 2.94%
1,695,504
+75,572
+5% +$1.5M
SNY icon
11
Sanofi
SNY
$107B
$32.9M 2.89%
698,046
+182,837
+35% +$8.82M
BTI icon
12
British American Tobacco
BTI
$136B
$32.3M 2.83%
607,800
+80,300
+15% +$4.36M
GSK icon
13
GSK
GSK
$104B
$30.3M 2.65%
702,051
+103,532
+17% +$4.04M
AQN icon
14
Algonquin Power & Utilities
AQN
$4.49B
$30M 2.63%
5,581,841
+740,872
+15% +$4.26M
GPN icon
15
Global Payments
GPN
$21.3B
$29.4M 2.58%
354,014
+101,256
+40% +$8.53M
PRDO icon
16
Perdoceo Education
PRDO
$1.99B
$26.7M 2.34%
709,582
+75,553
+12% +$2.42M
O icon
17
Realty Income
O
$61.3B
$26M 2.28%
428,239
+93,239
+28% +$5.43M
MO icon
18
Altria Group
MO
$124B
$26M 2.28%
393,705
+49,143
+14% +$3.11M
LBRT icon
19
Liberty Energy
LBRT
$3.89B
$25.8M 2.26%
2,089,283
+1,032,283
+98% +$11.9M
CVS icon
20
CVS Health
CVS
$137B
$23.6M 2.07%
313,427
-204,573
-39% -$14M
ET icon
21
Energy Transfer Partners
ET
$69.9B
$23.5M 2.06%
1,370,000
+335,000
+32% +$5.87M
TSLX icon
22
Sixth Street Specialty
TSLX
$1.66B
$19.9M 1.75%
871,433
-193,391
-18% -$4.65M
UGI icon
23
UGI
UGI
$7.85B
$19.8M 1.74%
596,607
+108,500
+22% +$3.79M
FCPT icon
24
Four Corners Property Trust
FCPT
$2.89B
$18.7M 1.64%
+765,275
New +$19.8M
SSNC icon
25
SS&C Technologies
SSNC
$16.8B
$17.7M 1.55%
198,967
+6,130
+3% +$531K

Similar funds

Callodine Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Callodine Capital Management held 57 positions worth $1.14B, up 18% from $966M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Callodine Capital Management deployed $140M of net new capital in Q3 2025, opening 10 new positions and adding to 31 existing holdings. Its largest new stake was Four Corners Property Trust: 765,275 shares worth $18.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Wolverine World Wide, an estimated $42M trimmed.

  • Callodine Capital Management's largest Q3 2025 buy was Four Corners Property Trust: 765,275 shares worth $18.7M.
  • Callodine Capital Management added most to Blue Owl Capital in Q3 2025, an estimated $26.3M increase.
  • Callodine Capital Management's biggest Q3 2025 reduction was Wolverine World Wide, cutting an estimated $42M.
  • Callodine Capital Management fully exited Delek US in Q3 2025, selling an estimated $15.2M.
  • Callodine Capital Management's ten largest holdings make up 50% of its $1.14B portfolio in Q3 2025.
  • Callodine Capital Management opened 10 new positions and closed 4 in Q3 2025.
  • Callodine Capital Management's portfolio value rose 18% quarter-over-quarter to $1.14B.

Based on Callodine Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.